Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > VIVXF AVIVAGEN INC > Key Indicators
VIVXF AVIVAGEN INC
0.054
-0.009-14.29%
YOY
Do not show
Hide blank lines
(Q3)2022/07/31(Q2)2022/04/30(Q1)2022/01/31(FY)2021/10/31
Financial Ratios
Efficiency Ratios TTM
Cash Conversion Cycle(D)
985.40% 666.2092 78.18% 144.1338 140.86% 55.849 1,962.91% 230.2774
Receivable Turnover(T)
63.75% 14.2661 -26.24% 10.9925 5.25% 13.5632 -31.42% 3.0662
Inventory Turnover(T)
-78.27% 0.1929 -39.72% 0.7492 -53.51% 1.0017 -43.59% 0.9302
Fixed Assets Turnover(T)
-41.36% 1.9704 61.39% 5.5465 76.20% 5.0599 -5.09% 3.9506
Total Asset Rate(T)
-62.14% 0.1238 -10.21% 0.2743 48.53% 0.6577 -20.91% 0.4584
ROA
-18.96% -198.585% -1.39% -128.614% -93.41% -336.659% 3.27% -226.185%
Efficiency Ratios
ROA 5 Year Average
-- -- -- -- -- -- -15.40% -198.867%
Profitability Ratios TTM
Gross Margin
15.96% 46.507% 7.98% 42.364% 7.40% 42.597% 3.11% 41.230%
Operating Margin
-298.96% -1282.134% -46.04% -363.994% -15.30% -313.091% -10.22% -316.948%
Net Margin
-214.24% -1604.602% -12.93% -468.947% -30.22% -511.869% -22.31% -493.380%
EBITDA Margin
-202.85% -11.4466% -5.41% -3.1802% -37.73% -3.752% -24.88% -3.6137%
R & D Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Sales Expense Ratio
-- 0.000% -- 0.000% -- 0.000% -- 0.000%
Administration Expense Rate
251.37% 1317.310% 26.42% 410.310% 1.84% 358.890% -1.55% 361.780%
Financial Health Ratios
Current Ratio
8.42% 0.8113 46.86% 1.4301 -6.20% 0.3684 -29.41% 0.5348
Quick Ratio
-40.46% 0.2978 1.21% 0.7818 -45.87% 0.1387 -43.35% 0.3071
GrowthRatios
Growth Ratios
Revenue CAGR(3Y)
-- -- -- -- -- -- -90.19% 6.510%
Revenue CAGR(5Y)
-- -- -- -- -- -- 6.99% 51.724%
Currency Unit
CADCADCADCAD

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
Avivagen, Inc. engages in the development and commercialization of products for livestock. Its products include OxC-beta Livestock, Vivamune Vital Health Chews and Oximunol Chewable Tablets. The company was founded by Janusz Daroszewsk and Graham W. Burton on August 4, 2005 and is headquartered in Ottawa, Canada.
CEO: Mr. Kym G.F. Anthony
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist